The comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A Scandinavian cohort study
Peter Ueda(Karolinska Institutet), Björn Pasternak(Phoenix Children's Hospital)
Cited by 31
Related Papers
The use of valproic acid and multiple sclerosis
|Pharmacoepidemiology and Drug Safety|2014|13